Svensson Lars G, Pillai Saila T, Rajeswaran Jeevanantham, Desai Milind Y, Griffin Brian, Grimm Richard, Hammer Donald F, Thamilarasan Maran, Roselli Eric E, Pettersson Gösta B, Gillinov A Marc, Navia Jose L, Smedira Nicholas G, Sabik Joseph F, Lytle Bruce W, Blackstone Eugene H
Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; Aorta Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
J Thorac Cardiovasc Surg. 2016 Mar;151(3):764-774.e4. doi: 10.1016/j.jtcvs.2015.10.113. Epub 2015 Nov 10.
To evaluate long-term results of aortic root procedures combined with ascending aorta replacement for aneurysms, using 4 surgical strategies.
From January 1995 to January 2011, 957 patients underwent 1 of 4 aortic root procedures: valve preservation (remodeling or modified reimplantation, n = 261); composite biologic graft (n = 297); composite mechanical graft (n = 156); or allograft root (n = 243).
Seven deaths occurred (0.73%), none after valve-preserving procedures, and 13 strokes (1.4%). Composite grafts exhibited higher gradients than allografts or valve preservation, but the latter 2 exhibited more aortic regurgitation (2.7% biologic and 0% mechanical composite grafts vs 24% valve-preserving and 19% allografts at 10 years). Within 2 to 5 years, valve preservation exhibited the least left ventricular hypertrophy, allograft replacement the greatest; however, valve preservation had the highest early risk of reoperation, allograft replacement the lowest. Patients receiving allografts had the highest risk of late reoperation (P < .05), and those receiving composite mechanical grafts and valve preservation had the lowest. Composite bioprosthesis patients had the highest risk of late death (57% at 15 years vs 14%-26% for the remaining procedures, P < .0001), because they were substantially older and had more comorbidities (P < .0001).
These 4 aortic root procedures, combined with ascending aorta replacement, provide excellent survival and good durability. Valve-preserving and allograft procedures have the lowest gradients and best ventricular remodeling, but they have more late regurgitation, and likely, less risk of valve-related complications, such as bleeding, hemorrhage, and endocarditis. Despite the early risk of reoperation, we recommend valve-preserving procedures for young patients when possible. Composite bioprostheses are preferable for the elderly.
采用4种手术策略评估主动脉根部手术联合升主动脉置换治疗动脉瘤的长期效果。
1995年1月至2011年1月,957例患者接受了4种主动脉根部手术中的1种:保留瓣膜(重塑或改良再植入,n = 261);复合生物移植物(n = 297);复合机械移植物(n = 156);或同种异体主动脉根部移植(n = 243)。
发生7例死亡(0.73%),保留瓣膜手术术后无死亡,13例卒中(1.4%)。复合移植物的梯度高于同种异体移植物或保留瓣膜手术,但后两者的主动脉反流更多(10年时,生物复合移植物为2.7%,机械复合移植物为0%,保留瓣膜手术为24%,同种异体移植物为19%)。在2至5年内,保留瓣膜手术导致的左心室肥厚最少,同种异体主动脉根部移植导致的左心室肥厚最大;然而,保留瓣膜手术的早期再次手术风险最高,同种异体主动脉根部移植的风险最低。接受同种异体移植物的患者晚期再次手术风险最高(P < 0.05),接受复合机械移植物和保留瓣膜手术的患者风险最低。复合生物假体患者的晚期死亡风险最高(15年时为57%,其余手术为14% - 26%,P < 0.0001),因为他们年龄更大且合并症更多(P < 0.0001)。
这4种主动脉根部手术联合升主动脉置换可提供良好的生存率和耐久性。保留瓣膜手术和同种异体主动脉根部移植手术的梯度最低,心室重塑最佳,但它们的晚期反流更多,且可能与瓣膜相关并发症(如出血、大出血和心内膜炎)的风险更低。尽管有早期再次手术的风险,但我们建议尽可能为年轻患者采用保留瓣膜手术。复合生物假体更适合老年人。